A Pilot Study of Abacavir/Lamivudine and Raltegravir in Antiretroviral-Naïve HIV-1–Infected Patients: 48-Week Results of the SHIELD Trial

Severe acute renal failure associated with rhabdomyolysis during treatment with raltegravir. A call for caution

(2010) Mar Masiá et al.   JOURNAL OF INFECTION

Markers of Inflammation, Coagulation, and Renal Function Are Elevated in Adults with HIV Infection

(2010) Jacqueline Neuhaus et al.   JOURNAL OF INFECTIOUS DISEASES

Severe rhabdomyolysis associated with raltegravir use

(2009) Teresa R Zembower et al.   AIDS

Randomized, double-blind, placebo-matched, multicenter trial of abacavir/lamivudine or tenofovir/emtricitabine with lopinavir/ritonavir for initial HIV treatment

(2009) Kimberly Y Smith et al.   AIDS

Acute Onset Insomnia Associated with the Initiation of Raltegravir: A Report of Two Cases and Literature Review

(2009) Jacob Gray et al.   AIDS PATIENT CARE AND STDS

Lipoprotein particle subclasses, cardiovascular disease and HIV infection

(2009) Daniel A. Duprez et al.   ATHEROSCLEROSIS

Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial

(2009) Jeffrey L Lennox et al.   LANCET

Exacerbation of depression associated with starting raltegravir: a report of four cases

(2008) Marianne Harris et al.   AIDS

Once-Daily Abacavir/Lamivudine and Ritonavir-Boosted Atazanavir for the Treatment of HIV-1 Infection in Antiretroviral-Naïve Patients: A 48-Week Pilot Study

(2008) Richard Elion et al.   HIV CLINICAL TRIALS